AB-1682 Health care coverage: scalp cooling
Sep 27, 2026 edition · GC-2026-0064 · Published 2026-09-27 · Version 2 · Proposed
Pending AB 1682 would cover prescribed FDA-cleared scalp cooling for chemotherapy-related hair loss in large-group coverage and conditionally in Medi-Cal.
What happened
AB 1682 proposes coverage of prescribed scalp cooling to reduce the incidence or severity of alopecia before, during or after chemotherapy involving hair-loss-inducing agents. The large-group contract and insurance provisions would apply to contracts issued, amended or renewed from January 1, 2027. They permit cost sharing, but on terms no less favorable than oncology supportive care under the same coverage. The proposal excludes specialized coverage and does not apply those commercial provisions to Medi-Cal managed care.
A separate Medi-Cal provision would cover the service subject to medical necessity, utilization controls, necessary federal approvals and available federal financial participation that is not jeopardized. Across the proposed provisions, scalp cooling means an FDA-cleared device or system; non-cleared cold caps and similarly marketed products are excluded. DHCS could issue implementation instructions without further regulatory action. Pending status at the coverage cutoff means these details support benefit-design preparation, rather than a representation that every chemotherapy patient already has this new entitlement.
Scope and timing
- Authority status
- Proposed
- Applicability
- Potentially applicable
- Audience
- Health systems, Provider networks
- Jurisdiction
- California
- Affected functions
- Managed Care, Revenue Cycle, IT, Clinical Operations, Compliance
- Responsible owner
- Managed Care
Why it matters
Large-group contract timing, device clearance and Medi-Cal’s federal conditions prevent the proposal from being read as one blanket benefit across every product.
Recommended action
Identify affected large-group products and prescribed devices, compare supportive-care cost sharing and assess Medi-Cal authorization and funding dependencies. Monitor the pending measure and governing implementation instructions.
Sources
- AB1682 proposed bill text, historical selected versionOfficial · California Legislature · 2026-08-30 · Source review 2026-10-15
- AB1682 official bill historyOfficial · California Legislature · Source review 2026-10-15
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Medicare & Medicaid report →